Pricing Log in Create free account
Friday 6 November 2026 Export GMED’s income statement to Excel — free account

Globus Medical, Inc.

GMED Healthcare Medical Devices

Globus Medical, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $2.9 billion, up 16.7% from fiscal 2024.

Revenue
−0.69%
EPS
+19.3%
Free cash flow
+10.1%

Quarter to September 2026, against a year earlier

72.22 9.22 −11.32%
Market cap
$10.9B
P/E
19.5×
Fwd P/E
18.8×
Dividend yield
—
F-score
9/9
Altman Z
11.30
Beneish M
−2.31
Dividend safety
n/a
Overview Business Profile Earnings & Analysis
Financials
Income Statement Balance Sheet Cash Flow Metrics & Ratios
Segments Valuation Filings

Globus Medical, Inc. (GMED) SEC filings, changes and red flags

Red flags

Filings

Form Period Filed What it reports Flags
10-Q Sep 30, 2026 P1I2: 5 added · 4 removed · 20 modified
P2I1A: no material changes, the filing says
8-K Nov 5, 2026 2.02 Results of operations and financial condition; 8.01 Other events; 9.01 Financial statements and exhibits
10-Q Jun 30, 2026 P1I2: 12 added · 2 removed · 16 modified
P2I1A: no material changes, the filing says
8-K Aug 6, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jun 3, 2026 5.02 Departure or appointment of directors or officers; 5.07 Submission of matters to a vote of security holders; 9.01 Financial statements and exhibits Officer departure
10-Q Mar 31, 2026
8-K May 7, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Mar 23, 2026 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-K Dec 31, 2025 1: 13 added · 7 removed · 59 modified
1A: 9 added · 19 removed · 94 modified
7: 12 added · 12 removed · 33 modified
8-K Feb 24, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 7, 2026 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2025
8-K Nov 6, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2025
8-K Aug 7, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jul 18, 2025 2.02 Results of operations and financial condition; 5.02 Departure or appointment of directors or officers; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits
10-Q Mar 31, 2025
8-K May 8, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-K Dec 31, 2024
8-K Feb 20, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 8, 2025 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Sep 30, 2024
8-K Nov 5, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
10-Q Jun 30, 2024
8-K Aug 6, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K May 7, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Feb 20, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Jan 10, 2024 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits
8-K Nov 7, 2023 2.02 Results of operations and financial condition; 9.01 Financial statements and exhibits

From the company’s filings on sec.gov. Red flags are raised by rules over the filings’ own data and text; they are not investment advice.